177 related articles for article (PubMed ID: 22354798)
21. Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Mandal S; Varma K; Jain S
Cytopathology; 2008 Apr; 19(2):127-9. PubMed ID: 18070116
[No Abstract] [Full Text] [Related]
22. [Malignant lymphoma of the skin].
Nakajima H; Miyamoto H
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
25. Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity.
Ok CY; Wang SA; Amin HM
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e123-6. PubMed ID: 24685107
[No Abstract] [Full Text] [Related]
26. Intracardiac right ventricular metastatic tumor of malignant T-cell lymphoma.
Sibbing D; Barthel P; Abbrederis K; Dennig K; Gaa J
Int J Cardiol; 2007 Apr; 117(2):e84-5. PubMed ID: 17331600
[No Abstract] [Full Text] [Related]
27. ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation.
Ando K; Tamada Y; Shimizu K; Akita Y; Watanabe D; Nakamura S; Hara K; Matsumoto Y
Acta Derm Venereol; 2010 Mar; 90(2):198-200. PubMed ID: 20169312
[No Abstract] [Full Text] [Related]
28. [Treatment of localized nasal NK/T-cell lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
[No Abstract] [Full Text] [Related]
29. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma.
Dunleavy K; Pittaluga S; Shovlin M; Roschewski M; Lai C; Steinberg SM; Jaffe ES; Wilson WH
Haematologica; 2016 Jan; 101(1):e27-9. PubMed ID: 26518748
[No Abstract] [Full Text] [Related]
31. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
32. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
Zheng W; Zhu J; Xie Y
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838
[No Abstract] [Full Text] [Related]
33. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
[TBL] [Abstract][Full Text] [Related]
34. Small cell variant of anaplastic large cell lymphoma: a 10-year review of the All Wales Lymphoma Panel database.
Youd E; Boyde AM; Attanoos RL; Dojcinov SD
Histopathology; 2009 Sep; 55(3):355-8. PubMed ID: 19723152
[No Abstract] [Full Text] [Related]
35. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.
Gómez-Román JJ; Cobo ML; Val-Bernal JF
Pathol Int; 2008 Apr; 58(4):249-52. PubMed ID: 18324919
[TBL] [Abstract][Full Text] [Related]
36. Mycosis fungoides bullosa.
Natsuga K; Shimizu T; Abe R; Kodama K; Shimizu H
Arch Dermatol; 2006 Jun; 142(6):793-5. PubMed ID: 16785397
[No Abstract] [Full Text] [Related]
37. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
[No Abstract] [Full Text] [Related]
38. Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Dawn G; Morrison A; Morton R; Bilsland D; Jackson R
Clin Exp Dermatol; 2003 Nov; 28(6):620-4. PubMed ID: 14616830
[TBL] [Abstract][Full Text] [Related]
39. [Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Takagi T; Sakai C; Oguro M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):917-20. PubMed ID: 1605671
[No Abstract] [Full Text] [Related]
40. [Total electron irradiation in T-cell lymphoma of the skin with a high degree of malignancy].
Potekaev NS; Pavlov AS; Vorob'ev AI; Torshilova VN; Shuginina EA
Ter Arkh; 1989; 61(7):132-3. PubMed ID: 2686063
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
